Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSui, S.X.-
dc.contributor.authorHordacre, B.-
dc.contributor.authorPasco, J.A.-
dc.identifier.citationBiomedicines, 2021; 9(2):1-14-
dc.description.abstractStroke is a leading cause of death and disability and is responsible for a significant economic burden. Sarcopenia and cognitive dysfunction are common consequences of stroke, but there is less awareness of the concurrency of these conditions. In addition, few reviews are available to guide clinicians and researchers on how to approach sarcopenia and cognitive dysfunction as comorbidities after stroke, including how to assess and manage them and implement interventions to improve health outcomes. This review synthesises current knowledge about the relationship between post-stroke sarcopenia and cognitive dysfunction, including the physiological pathways, assessment tools, and interventions involved.-
dc.description.statementofresponsibilitySophia X. Sui, Brenton Hordacre and Julie A. Pasco-
dc.rights© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// 4.0.-
dc.subjectcognitive dysfunction-
dc.subjectpost stroke-
dc.titleAre sarcopenia and cognitive dysfunction comorbid after stroke in the context of brain–muscle crosstalk?-
dc.typeJournal article-
dc.identifier.orcidHordacre, B. [0000-0002-7129-6684]-
Appears in Collections:Aurora harvest 4
Pharmacology publications

Files in This Item:
File Description SizeFormat 
hdl_130434.pdfPublished version244.98 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.